Todd Watanabe
Reporting Person's title: President and Chief Executive Officer, Director · Arcutis Biotherapeutics, Inc.
- 2024
- Aug 6, 2026
- 13
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Todd Watanabe files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Masaru Matsuda - $2.21M in ARQT purchases and sales in the last 12 months
- Howard G. Welgus - $1.95M in ARQT purchases and sales in the last 12 months
- Patrick Burnett - $1.56M in ARQT purchases and sales in the last 12 months
- Keith R. Leonard - $997K in ARQT purchases and sales in the last 12 months
- Terrie Curran - $984K in ARQT purchases and sales in the last 12 months
- Neha Krishnamohan - $939K in ARQT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Todd Watanabe?
Todd Watanabe is a corporate insider, tracked as Reporting Person's title: President and Chief Executive Officer, Director of Arcutis Biotherapeutics, Inc. (ARQT). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Todd Watanabe submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Todd Watanabe been buying or selling stock?
Recorded transactions: 2 open-market purchases ($21K) and 18 open-market sales ($6.01M) across all tracked filings.
